RISCUL CARDIOVASCULAR AL HALOPERIDOLULUI VERSUS ANTIPSIHOTICE ATIPICE ÎN TERAPIA SCHIZOFRENIEI
Irina Dobrin, Romeo Dobrin, Gabriela Elena Chele, Cristinel Ștefănescu, Anton Knieling, Roxana Chiriță
Abstract
Irina Dobrin, Romeo Dobrin, Gabriela Elena Chele, Cristinel Ștefănescu, Anton Knieling, Roxana Chiriță
Abstract
The present study examined thesafety of the atypical antipsychotic drugs sertindol, olanzapine and quetiapine used in thetreatment of schizophrenia. Haloperidol, a typical antipsychotic drug, was used for comparison.These data may account for the different therapeutic effects and side-effect profiles (cardiovascularrisk) of typical and atypical antipsychotic drugs in schizophrenia.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The present study examined thesafety of the atypical antipsychotic drugs sertindol, olanzapine and quetiapine used in thetreatment of schizophrenia. Haloperidol, a typical antipsychotic drug, was used for comparison.These data may account for the different therapeutic effects and side-effect profiles (cardiovascularrisk) of typical and atypical antipsychotic drugs in schizophrenia.
Key concepts: Olanzapine, Quetiapine, Atypical antipsychotic, Schizophrenia (object-oriented programming), Antipsychotic, Haloperidol, Antipsychotic drug, Medicine